|
Evidence Based Laboratory Medicine and Test Utilization
Citations 211-220 of 441 total displayed.
|
Past content
(since Jan 1997):
|
- Opinion
Proposed Cardiovascular Risk Assessment Algorithm Using High-Sensitivity C-Reactive Protein and Lipid Screening
- Nader Rifai and Paul M. Ridker
Clin. Chem. 2001; 47: 28-30.
[Extract]
[Full text]
[PDF]
- Evidence-based Laboratory Medicine and Test Utilization
Effect of Urgent Clinician Notification of Low Hemoglobin Values
- Paul Froom, Tayser Mahameed, Rosa Havis, and Mira Barak
Clin. Chem. 2001; 47: 63-66.
[Abstract]
[Full text]
[PDF]
- Evidence-based Laboratory Medicine and Test Utilization
Patient-derived Quality Specifications for Instruments Used in Self-Monitoring of Blood Glucose
- Svein Skeie, Geir Thue, and Sverre Sandberg
Clin. Chem. 2001; 47: 67-73.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
Data Inconsistencies in Abstracts of Articles in Clinical Chemistry
- Robert Siebers
Clin. Chem. 2001; 47: 149.
[Extract]
[Full text]
[PDF]
- Reviews
Should We Use Carbohydrate-deficient Transferrin instead of  -Glutamyltransferase for Detecting Problem Drinkers? A Systematic Review and Metaanalysis
- Kay Scouller, Katherine M. Conigrave, Petra Macaskill, Les Irwig, and John B. Whitfield
Clin. Chem. 2000; 46: 1894-1902.
[Abstract]
[Full text]
[PDF]
- National Academy of Clinical Biochemistry
Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
- D. Robert Dufour, John A. Lott, Frederick S. Nolte, David R. Gretch, Raymond S. Koff, and Leonard B. Seeff
Clin. Chem. 2000; 46: 2027-2049.
[Abstract]
[Full text]
[PDF]
- National Academy of Clinical Biochemistry
Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring
- D. Robert Dufour, John A. Lott, Frederick S. Nolte, David R. Gretch, Raymond S. Koff, and Leonard B. Seeff
Clin. Chem. 2000; 46: 2050-2068.
[Abstract]
[Full text]
[PDF]
- Evidence-based Laboratory Medicine and Test Utilization
Evaluation of Indicators of Cobalamin Deficiency Defined as Cobalamin-induced Reduction in Increased Serum Methylmalonic Acid
- Bjørn J. Bolann, Jan Dag Solli, Jörn Schneede, Kjell A. Grøttum, Arne Loraas, Morgan Stokkeland, Asbjørn Stallemo, Arne Schjøth, Rolf Bruun Bie, Helga Refsum, and Per Magne Ueland
Clin. Chem. 2000; 46: 1744-1750.
[Abstract]
[Full text]
[PDF]
- Technical Briefs
Inaccuracy of Calculated LDL-Cholesterol in Type 2 Diabetes: Consequences for Patient Risk Classification and Therapeutic Decisions
- Ana Maria Wägner, José Luis Sánchez-Quesada, Antonio Pérez, Mercedes Rigla, Mariano Cortés, Francisco Blanco-Vaca, and Jordi Ordóñez-Llanos
Clin. Chem. 2000; 46: 1830-1832.
[Extract]
[Full text]
[PDF]
- Evidence Based Laboratory Medicine and Test Utilization
Serum Procalcitonin Concentrations in Term Delivering Mothers and Their Healthy Offspring: A Longitudinal Study
- Marcello Assumma, Fabrizio Signore, Lucia Pacifico, Naila Rossi, John F. Osborn, and Claudio Chiesa
Clin. Chem. 2000; 46: 1583-1587.
[Abstract]
[Full text]
[PDF]
|
|
